Elizabeth A. Doherty Ph.D.
Liz Doherty is of counsel in Finnegan's Brussels, Belgium office. She assists clients in the biotechnology and chemical arts in all aspects of U.S. patent law, from prosecution to litigation. Dr. Doherty also works directly with Finnegan's European patent attorneys to assist with European patent prosecution. Her extensive U.S. patent experience coupled with her knowledge of the European Patent Convention allows her to coordinate U.S. and European patent proceedings and to assist clients in developing global patent strategies. She conducts business in French as well as English.
Dr. Doherty's U.S. patent work includes prosecuting applications and handling inter partes reviews and reexaminations before the U.S. Patent and Trademark Office, providing validity and infringement opinions, performing due diligence reviews, and preparing clients for U.S. litigation. Dr. Doherty has also assisted in a number of U.S. patent litigations, including three Abbreviated New Drug Application (ANDA) litigations. In addition, she has worked closely with U.S. regulatory counsels to assist several pharmaceutical clients in coordinating their patent and regulatory strategies.
Dr. Doherty gained experience in both patent prosecution and strategic counseling at the firm while in law school, first as a technical specialist and then as a student associate.
- Joined Finnegan in 2000 after a nine year career in basic research at the University of California and Yale University.
- Ph.D. research focused on X-ray crystallography and the biochemistry of nucleic acids, including large RNA catalysts.
- Frequent speaker on United States patent law issues.